About MCAL Therapeutics
MCAL Therapeutics is a private company based in Park City, Utah, incorporated in 2020 in Delaware. It has reported $6,337,543 raised in two offerings on Form D since June 2020. Its chief executive is Tom Gadek.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2024 | Mar 27, 2024 | $5,887,549fully sold | 29 | $203K | EquityRule 506(b) | Form D ↗ |
| May 20, 2020 | Jun 4, 2020 | $449,994fully sold | 5 | $89,999 | Equity, Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, two offerings | $6,337,543 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on MCAL Therapeutics's Form D filed Mar 27, 2024.
TG
Tom Gadek
Chief Executive Officer and director
CN
Charles O'Neill
Director
CM
Chris Murphy
Director
DA
Dan Albert
Director
TM
Tom Mather
Director
Earlier filings also listed Tanya Shnaydman (executive officer, last listed Jun 2020).